Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Cell
|
June 11, 2013
HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia
Matthew D Galbraith, Mary A Allen, Claire L Bensard, et al.
Blood Advances
|
March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
L Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Cancer Research
|
January 5, 2019
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell Program
Michael U J Oliphant, Melanie Y Vincent, Matthew D Galbraith, et al.
Elife
|
May 29, 2014
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
Mary Ann Allen, Zdenek Andrysik, Veronica L Dengler, et al.
Cell Reports
|
March 10, 2023
FAM193A is a positive regulator of p53 activity
Maria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife
|
July 30, 2016
Trisomy 21 consistently activates the interferon response
Kelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Cell Reports
|
January 15, 2026
Altered hepatic metabolism in Down syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Altered Hepatic Metabolism in Down Syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Annals of Clinical and Translational Neurology
|
February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder
Jonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Elife
|
February 10, 2025
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
Kira A Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Cell
|
June 11, 2013
HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia
Matthew D Galbraith, Mary A Allen, Claire L Bensard, et al.
Blood Advances
|
March 31, 2021
Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation
L Alexander Liggett, Matthew D Galbraith, Keith P Smith, et al.
Cancer Research
|
January 5, 2019
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell Program
Michael U J Oliphant, Melanie Y Vincent, Matthew D Galbraith, et al.
Elife
|
May 29, 2014
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
Mary Ann Allen, Zdenek Andrysik, Veronica L Dengler, et al.
Cell Reports
|
March 10, 2023
FAM193A is a positive regulator of p53 activity
Maria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife
|
July 30, 2016
Trisomy 21 consistently activates the interferon response
Kelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Cell Reports
|
January 15, 2026
Altered hepatic metabolism in Down syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Altered Hepatic Metabolism in Down Syndrome
Lauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Annals of Clinical and Translational Neurology
|
February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder
Jonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Elife
|
February 10, 2025
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
Kira A Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Page
of 7